Focused on restoring vision

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision.

See what sets us apart

Realizing full potential of Aceclidine for the treatment of presbyopia

Our novel and lead program aims to provide an ideal pharmaceutical presbyopia solution to restore near vision, with the potential for broadest target patient population.

Discover our science

Pursuing treatment to give freedom from reading glasses

Presbyopia is the inevitable loss of near vision that that impacts nearly 2B people globally.

See what we’re developing

A company connected by passion and purpose

Our team is filled with ambitious individuals from across the pharmaceutical and eye care industry who are motivated to improve vision.

Work with us

Corporate Presentation

Download Presentation

LENZ Therapeutics and Graphite Bio Announce Merger Agreement

Download Presentation

Phase 2: Insight Trial

Download Presentation